| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae15396132411fbb4b24a51c72d80846 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a7112c1dde44143caa7199b5dcc2b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93537993c40617cf2f3ba64c3c6aa8aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75322b53e64470aa46ed6c3f3a447a29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1eaca698a12d102fb6187d3d44b8a76 |
| publicationDate |
2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019219080-A1 |
| titleOfInvention |
Pharmaceutical combination for treating brain edema with intracellular osmotic pressure as target |
| abstract |
A pharmaceutical composition for treating brain edema and a preparation method therefor. The active ingredients of the compound pharmaceutical composition include sennoside A, cantharidin or a derivative thereof, nimodipine or nifedipine, cinepazide maleate and edaravone. Cellular experiments are used to find active drugs and combinations thereof that can reduce colloidal osmotic pressure and crystal osmotic pressure in brain cells to treat brain edema and provide new pharmaceutical use in clinical applications. |
| priorityDate |
2018-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |